Reliability and Validity of Korean Bowel Disease Questionnaire for Functional Gastrointestinal Disorders.
10.12771/emj.2011.34.2.39
- Author:
Hyun Joo SONG
1
;
Hye Kyung JUNG
Author Information
1. Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.
- Publication Type:Original Article
- Keywords:
Dyspepsia;
Irritable bowel syndrome;
Prevalence;
Questionnaire
- MeSH:
Abdominal Pain;
Dyspepsia;
Endoscopy;
Female;
Gastrointestinal Diseases;
Health Promotion;
Humans;
Irritable Bowel Syndrome;
Male;
Prevalence;
Reproducibility of Results;
Rome;
Surveys and Questionnaires
- From:The Ewha Medical Journal
2011;34(2):39-46
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: The Korean version of Bowel disease questionnaire (BDQ-K) was developed to evaluate the symptom items required to meet the definition of functional gastrointestinal disorders (FGIDs). We evaluated the test-retest reliability and validity of the self-reported BDQ-K and prevalence of functional dyspepsia (FD) and irritable bowel syndrome (IBS) according to the Rome-III criteria. METHODS: Sixty-nine patients participated in the test-retest reliability study, with a two week interval, and another 74 patients were enrolled to assess the self-reported questionnaire versus a doctor's interview (concurrent validity). A total of 3,325 subjects (mean age, 44+/-9 yrs; 58.3% male) presenting for an upper endoscopy responded to the BDQ-K at a health promotion center, but 797 subjects with organic diseases were excluded. RESULTS: In the validity study of the BDQ-K, the median kappa value was 0.74 (0.36~1.0). The median kappa value for the test-retest was 0.56 (range 0.22~1.0), including abdominal pain (kappa=0.51, P<0.001), pain onset before 6 months (kappa=0.51, P<0.001), epigastric pain (kappa=0.69, P<0.001), early satiety (kappa=0.40, P<0.001), and postprandial fullness (kappa=0.34, P<0.001). The prevalence of FD was 8.3% (209/2,528); epigastric pain more than once a week 4.4%, early satiety 2.5%, and postprandial fullness 6.1%. FD was more prevalent in women (P=0.001). The prevalence of IBS was 6.1% and IBS also predominated in women (7.1% vs 5.1% in men, P=0.032). CONCLUSION: The BDQ-K is a reliable and valid instrument for identifying FGIDs. The prevalence of FD according to the Rome III criteria was 8.3% and that of IBS was 6.1%.
